Sexual Dysfunction News and Research

Latest Sexual Dysfunction News and Research

Research reveals link between concussions and erectile dysfunction in former NFL players

Former professional football players who have experienced concussion symptoms, including loss of consciousness, disorientation or nausea after a head injury, are more likely to report low testosterone and erectile dysfunction (ED), according to research published Aug. 26 in JAMA Neurology.

26 Aug 2019

Regular consumption of nuts improves sexual function

Researchers from the Human Nutrition Unit of the Universitat Rovira i Virgili (Tarragona/Spain) and the Pere Virgili Health Research Institute have found that consuming 60 grams of nuts a day improves sexual function.

24 Jul 2019

Study identifies psychosocial factors that affect sexual satisfaction in postmenopausal women

The number of women regularly having sex declines with age, and the number of women enjoying sex postmenopause is even lower.

10 Jul 2019

FDA approves new drug to treat hypoactive sexual desire disorder in premenopausal women

The U.S. Food and Drug Administration today approved Vyleesi (bremelanotide) to treat acquired, generalized hypoactive sexual desire disorder in premenopausal women.

23 Jun 2019

Is it a feminist right to want more sex? One company thinks a pill is the answer

Studies have never defined a "normal" level of sexual desire. Despite that, there's a website and an online quiz to help you decide if you've got a problem. Called "Right to Desire," it brands libido as a feminist "right," and its home page offers the defiant, in-your-face prompt: "Yes, I want my desire back."

11 May 2019

FDA issues safety labeling changes for female sexual dysfunction treatment

The U.S. Food and Drug Administration today issued a safety labeling change order to Sprout Pharmaceuticals for their drug, Addyi (flibanserin), that requires the company to revise important safety information that women and their health care professionals need to have when considering use of the drug.

12 Apr 2019

Inflammatory arthritis may impact intimacy, sexual function for men and women

A systematic review and analysis of published studies found consistent links between inflammatory arthritis and impacts on intimacy and sexual function for both men and women. The Arthritis Care & Research analysis included 55 studies.

3 Apr 2019

The high cost of sex: Insurers often don’t pay for drugs to treat problems

For some older people, the joy of sex may be tempered by financial concerns: Can they afford the medications they need to improve their experience between the sheets?

19 Feb 2019

Johns Hopkins Greenberg Bladder Cancer Institute awards research grants to study how bladder cancer affects women

The Johns Hopkins Greenberg Bladder Cancer Institute awarded research grants to four projects that focus on understanding how treatment of bladder cancer affects women, why the disease has a less favorable outcome for women than men, and how biology could play a role in offering new targets for cancer therapy.

1 Feb 2019

Sexual function in women with vulva pain improved with oral nerve pain medication

Women with chronic pain or discomfort around the vulva showed improved sexual function with an oral nerve pain medication used to treat pain caused by a previous herpes infection as well as fibromyalgia, according to a Rutgers study.

2 Jan 2019

Survey shows negative effect of vulvovaginal atrophy symptoms on quality of life for women

With symptoms such as dryness, burning, or itching of the vagina, vulvovaginal atrophy is estimated to affect up to 98% of postmenopausal women, many of whom will fail to report symptoms to their healthcare providers or seek help.

14 Nov 2018

Hormone injections reduce risk for early menopause from breast cancer chemotherapy

Final results of SWOG Cancer Research Network's groundbreaking international Prevention of Early Menopause Study clinical trial are in, and they show continued evidence that women who get injections of the hormone drug goserelin along with standard breast cancer chemotherapy are more likely to become pregnant - without developing negative side effects or shortening their lives.

29 Oct 2018

Medicare incurs more than $1.2 billion over prostate cancer care in older men

Researchers from the University of North Carolina Lineberger Comprehensive Cancer Center estimate that screening for and treating prostate cancer in men aged 70 years or older, which is not recommended by national guidelines, cost Medicare more than $1.2 billion over a three year period for each group of men diagnosed in the United States each year.

14 Sep 2018

Nerve stimulation therapy may offer new hope for women with sexual dysfunction

Electrodes aren't the first thing most people think of when it comes to achieving sexual arousal. But if the results of a pilot study are any indication, that may soon change.

5 Sep 2018

Dr. Clinton Webb selected for top award from AHA Council on Hypertension

Dr. R. Clinton Webb, Herbert S. Kupperman Chair in Cardiovascular Disease in the Department of Physiology at the Medical College of Georgia at Augusta University, has been selected for the top award from the American Heart Association's Council on Hypertension.

4 Sep 2018

Survey: Only half of health care practitioners ask for patients’ sexual orientation

Johns Hopkins Medicine researchers say their small survey of nearly 100 health care practitioners who are members of the Sexual Medicine Society of North America revealed that only half routinely ask their patients directly about their sexual orientation.

1 Aug 2018

“Vaginal rejuvenation” procedures and devices unsafe says FDA

According to a warning from the United States Food and Drugs Administration (FDA), devices that are being sold for “vaginal rejuvenation” in women who are suffering from urinary incontinence or menopausal and sexual symptoms, can cause serious harm.

31 Jul 2018

Can-Fite BioPharma receives Australian and Chinese patents for new drug to treat erectile dysfunction

Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address liver diseases, inflammatory diseases and sexual dysfunction, today announced that the Australian and Chinese patent offices have granted the Company a patent for the utilization of A3 adenosine receptor ligands in the treatment of sexual dysfunction, in a patent (Australian, No. 2013301125ZL, Chinese No. 2013800472970) titled, "A3 adenosine receptor ligands for use in treatment of a sexual dysfunction."

17 Jul 2018

U.S. researchers recommend development of anti-cancer drugs based on mechanism of Namodenoson

Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases, today announced that U.S. researchers published scientific findings recommending development of anti-Liver Cancer Drugs based on a mechanism of action utilized by Namodenoson.

2 Jul 2018

Can-Fite provides update on Phase II clinical trial with drug candidate Namodenoson

Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases, today provided an update on its Phase II clinical trial with drug candidate Namodenoson in the treatment of advanced hepatocellular carcinoma in patients whose disease has progressed on sorafenib therapy.

19 Jun 2018

Sexual Dysfunction News and Research

Latest Sexual Dysfunction News and Research

Research reveals link between concussions and erectile dysfunction in former NFL players

Regular consumption of nuts improves sexual function

Study identifies psychosocial factors that affect sexual satisfaction in postmenopausal women

FDA approves new drug to treat hypoactive sexual desire disorder in premenopausal women

Is it a feminist right to want more sex? One company thinks a pill is the answer

FDA issues safety labeling changes for female sexual dysfunction treatment

Inflammatory arthritis may impact intimacy, sexual function for men and women

The high cost of sex: Insurers often don’t pay for drugs to treat problems

Johns Hopkins Greenberg Bladder Cancer Institute awards research grants to study how bladder cancer affects women

Sexual function in women with vulva pain improved with oral nerve pain medication

Survey shows negative effect of vulvovaginal atrophy symptoms on quality of life for women

Hormone injections reduce risk for early menopause from breast cancer chemotherapy

Medicare incurs more than $1.2 billion over prostate cancer care in older men

Nerve stimulation therapy may offer new hope for women with sexual dysfunction

Dr. Clinton Webb selected for top award from AHA Council on Hypertension

Survey: Only half of health care practitioners ask for patients’ sexual orientation

“Vaginal rejuvenation” procedures and devices unsafe says FDA

Can-Fite BioPharma receives Australian and Chinese patents for new drug to treat erectile dysfunction

U.S. researchers recommend development of anti-cancer drugs based on mechanism of Namodenoson

Can-Fite provides update on Phase II clinical trial with drug candidate Namodenoson

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Sexual Dysfunction News and Research

Latest Sexual Dysfunction News and Research

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in